Anne Juul Bjertrup
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne Juul Bjertrup has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Kamilla Woznica Miskowiak
University of Copenhagen
8 shared publications - Hanne Lie Kjærstad
Neurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark
5 shared publications - Lars Vedel Kessing
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
5 shared publications - Maj Vinberg
Mental Health Center North Zealand, Copenhagen University Hospital
4 shared publications - Jeff Zarp
Neurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Copenhagen, Denmark
3 shared publications - Karoline Holm Elkjær Rasmussen
Neurocognition and Emotion Across Disorders of the Brain (NEAD) Centre, Psychiatric Centre Copenhagen, Frederiksberg Hospital, Department of Psychology, University of Copenhagen, Øster Farimagsgade 2A, DK-1353, Copenhagen, Denmark
3 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 189, 106827
Rhythms of interaction – the timescales of social coordination and why they matter
- 3 July 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 189, 106827
Open AccessRhythms of interaction – the timescales of social coordination and why they matter
- 19 February 2026
- Published by Wiley in Bipolar Disorders
- Vol. 28 (2) , e70095
Cognitive Complaints in Bipolar Disorder: Relation to Estimated Illness‐Related Objective Cognitive Decline, Functioning, and Quality of Life
Objectives: Persons with bipolar disorder (BD) often present with cognitive complaints even in the absence of objective cognitive impairment as measured with neuropsychological tests. It remains unclear whether cognitive complaints reflect negative bias or illness‐related decline from premorbid functioning, affecting functioning and quality of life (QoL). Methods: Data from n = 498 persons with BD and n = 320 healthy controls (HC) were included from a database based on seven studies. We calculated IQ‐objective cognition discrepancy scores (−10 to +10; negative scores = lower cognitive performance than premorbid IQ, i.e., estimated ‘loss of function’) and subjective‐objective cognitive discrepancy scores (−10 to +10; negative scores = less subjective than objective difficulties; positive scores = more subjective than objective impairments). We investigated associations between these variables and subjective cognitive complaints, functioning, and QoL with multiple regression models. Results: Subjective cognitive complaints were associated with poorer global cognitive performance relative to premorbid IQ (i.e., estimated ‘loss of function’). More subjective than objective cognitive difficulties was associated with diminished functioning and QoL. A similar association was seen for objective cognitive performance. Conclusions: Subjective complaints may indicate a decline from premorbid cognitive function, even if objective cognitive performance is within the normal range after illness onset. More subjective than objective impairment correlates with poorer functioning and QoL. Hence, cognitive management initiatives should be centered around patients with cognitive complaints independent of objective cognitive status.
- 19 February 2026
- Published by Wiley in Bipolar Disorders
- Vol. 28 (2) , e70095
Cognitive Complaints in Bipolar Disorder: Relation to Estimated Illness‐Related Objective Cognitive Decline, Functioning, and Quality of Life
Objectives: Persons with bipolar disorder (BD) often present with cognitive complaints even in the absence of objective cognitive impairment as measured with neuropsychological tests. It remains unclear whether cognitive complaints reflect negative bias or illness‐related decline from premorbid functioning, affecting functioning and quality of life (QoL). Methods: Data from n = 498 persons with BD and n = 320 healthy controls (HC) were included from a database based on seven studies. We calculated IQ‐objective cognition discrepancy scores (−10 to +10; negative scores = lower cognitive performance than premorbid IQ, i.e., estimated ‘loss of function’) and subjective‐objective cognitive discrepancy scores (−10 to +10; negative scores = less subjective than objective difficulties; positive scores = more subjective than objective impairments). We investigated associations between these variables and subjective cognitive complaints, functioning, and QoL with multiple regression models. Results: Subjective cognitive complaints were associated with poorer global cognitive performance relative to premorbid IQ (i.e., estimated ‘loss of function’). More subjective than objective cognitive difficulties was associated with diminished functioning and QoL. A similar association was seen for objective cognitive performance. Conclusions: Subjective complaints may indicate a decline from premorbid cognitive function, even if objective cognitive performance is within the normal range after illness onset. More subjective than objective impairment correlates with poorer functioning and QoL. Hence, cognitive management initiatives should be centered around patients with cognitive complaints independent of objective cognitive status.
- 10 October 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 393 (Pt B) , 120405
Childhood maltreatment and impaired emotion regulation and processing in remitted affective disorders: Evidence from a large-scale investigation
- 10 October 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 393 (Pt B) , 120405
Childhood maltreatment and impaired emotion regulation and processing in remitted affective disorders: Evidence from a large-scale investigation
- 6 August 2025
- Published by Elsevier in Behavioural Brain Research
- Vol. 495, 115766
Neurocognitive response to fearful faces in mothers
- 6 August 2025
- Published by Elsevier in Behavioural Brain Research
- Vol. 495, 115766
Neurocognitive response to fearful faces in mothers
- 25 February 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 378, 58-73
Psychological prevention of postpartum depression for expectant parents
- 25 February 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 378, 58-73
Psychological prevention of postpartum depression for expectant parents
- Open Access
- 12 February 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e45
Neural subgroups in unaffected first-degree relatives of patients with bipolar disorder during emotion regulation
Background: Impaired emotion regulation has been proposed as a putative endophenotype in bipolar disorder (BD). Functional magnetic resonance imaging (fMRI) studies investigating this in unaffected first-degree relatives (UR) have thus far yielded incongruent findings. Hence, the current paper examines neural subgroups among UR during emotion regulation. Methods: 71 UR of patients with BD and 66 healthy controls (HC) underwent fMRI scanning while performing an emotion regulation task. Hierarchical cluster analysis was performed on extracted signal change during emotion down-regulation in pre-defined regions of interest (ROIs). Identified subgroups were compared on neural activation, demographic, clinical, and cognitive variables. Results: Two subgroups of UR were identified: subgroup 1 (39 UR; 55%) was characterized by hypo-activity in the dorsolateral, dorsomedial, and ventrolateral prefrontal cortex and the bilateral amygdalae, but comparable activation to HC in the other ROIs; subgroup 2 (32 UR; 45%) was characterized by hyperactivity in all ROIs. Subgroup 1 had lower success in emotion regulation compared to HC and reported more childhood trauma compared to subgroup 2 and HC. Subgroup 2 reported more anxiety, lower functioning, and greater attentional vigilance toward fearful faces compared to HC. Relatives from both subgroups were poorer in recognizing positive faces compared to HC. Conclusions: These findings may explain the discrepancy in earlier fMRI studies on emotion regulation in UR, showing two different subgroups of UR that both exhibited aberrant neural activity during emotion regulation, but in opposite directions. Furthermore, the results suggest that impaired recognition of positive facial expressions is a broad endophenotype of BD.
- 12 February 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e45
Open AccessNeural subgroups in unaffected first-degree relatives of patients with bipolar disorder during emotion regulation
Background: Impaired emotion regulation has been proposed as a putative endophenotype in bipolar disorder (BD). Functional magnetic resonance imaging (fMRI) studies investigating this in unaffected first-degree relatives (UR) have thus far yielded incongruent findings. Hence, the current paper examines neural subgroups among UR during emotion regulation. Methods: 71 UR of patients with BD and 66 healthy controls (HC) underwent fMRI scanning while performing an emotion regulation task. Hierarchical cluster analysis was performed on extracted signal change during emotion down-regulation in pre-defined regions of interest (ROIs). Identified subgroups were compared on neural activation, demographic, clinical, and cognitive variables. Results: Two subgroups of UR were identified: subgroup 1 (39 UR; 55%) was characterized by hypo-activity in the dorsolateral, dorsomedial, and ventrolateral prefrontal cortex and the bilateral amygdalae, but comparable activation to HC in the other ROIs; subgroup 2 (32 UR; 45%) was characterized by hyperactivity in all ROIs. Subgroup 1 had lower success in emotion regulation compared to HC and reported more childhood trauma compared to subgroup 2 and HC. Subgroup 2 reported more anxiety, lower functioning, and greater attentional vigilance toward fearful faces compared to HC. Relatives from both subgroups were poorer in recognizing positive faces compared to HC. Conclusions: These findings may explain the discrepancy in earlier fMRI studies on emotion regulation in UR, showing two different subgroups of UR that both exhibited aberrant neural activity during emotion regulation, but in opposite directions. Furthermore, the results suggest that impaired recognition of positive facial expressions is a broad endophenotype of BD.
- Open Access
- 28 January 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 375, 239-248
Cognitive hierarchy in mood disorders and relations to daily functioning
- 28 January 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 375, 239-248
Open AccessCognitive hierarchy in mood disorders and relations to daily functioning
- Open Access
- 28 November 2024
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 92, 1-9
Optimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality
- 28 November 2024
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 92, 1-9
Open AccessOptimizing differential diagnostics and identifying transdiagnostic treatment targets using virtual reality
- Open Access
- 15 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-13
Prenatal affective cognitive training to reduce the risk of postpartum depression (PACT): study protocol for a randomized controlled trial
Background: Postpartum depression (PPD) affects 30–50% of women with a history of previous depression or bipolar disorder and 8% of women with no history of depression. Negative cognitive biases in the perception of infant cues and difficulties with emotion regulation are replicated risk factors. Current interventions focus on detecting and treating rather than preventing PPD. The aim of this randomized controlled intervention trial is therefore to investigate the potential prophylactic effects of prenatal affective cognitive training for pregnant women at heightened risk of PPD. Methods: The study will enrol a total of 292 pregnant women: 146 at high risk and 146 at low risk of PPD. Participants undergo comprehensive assessments of affective cognitive processing, clinical depressive symptoms, and complete questionnaires at baseline. Based on the responses, pregnant women will be categorized as either at high or low risk of PPD. High-risk participants will be randomized to either prenatal affective cognitive training (PACT) or care as usual (CAU) immediately after the baseline testing. The PACT intervention is based on emerging evidence for efficacy of affective cognitive training approaches in depression, including cognitive bias modification, attention bias modification, mindfulness-inspired emotion regulation exercises, and working memory training. Participants randomised to PACT will complete five individual computerised and virtual reality-based training sessions over 5 weeks. The primary outcome is the difference between intervention arms in the incidence of PPD, assessed with an interview 6 months after birth. We will also assess the severity of depressive symptoms, rated weekly online during the first 6 weeks postpartum. Discussion: The results will have implications for future early prophylactic interventions for pregnant women at heightened risk of PPD. If the PACT intervention reduces the incidence of PPD, it can become a feasible, non-invasive prophylactic strategy during pregnancy, with positive mental health implications for these women and their children. Trial registration: ClinicalTrials.gov NCT06046456 registered 21-09-2023, updated 08-07-2024.
- 15 July 2024
- Published by Springer Nature in Trials
- Vol. 25 (1) , 1-13
Open AccessPrenatal affective cognitive training to reduce the risk of postpartum depression (PACT): study protocol for a randomized controlled trial
Background: Postpartum depression (PPD) affects 30–50% of women with a history of previous depression or bipolar disorder and 8% of women with no history of depression. Negative cognitive biases in the perception of infant cues and difficulties with emotion regulation are replicated risk factors. Current interventions focus on detecting and treating rather than preventing PPD. The aim of this randomized controlled intervention trial is therefore to investigate the potential prophylactic effects of prenatal affective cognitive training for pregnant women at heightened risk of PPD. Methods: The study will enrol a total of 292 pregnant women: 146 at high risk and 146 at low risk of PPD. Participants undergo comprehensive assessments of affective cognitive processing, clinical depressive symptoms, and complete questionnaires at baseline. Based on the responses, pregnant women will be categorized as either at high or low risk of PPD. High-risk participants will be randomized to either prenatal affective cognitive training (PACT) or care as usual (CAU) immediately after the baseline testing. The PACT intervention is based on emerging evidence for efficacy of affective cognitive training approaches in depression, including cognitive bias modification, attention bias modification, mindfulness-inspired emotion regulation exercises, and working memory training. Participants randomised to PACT will complete five individual computerised and virtual reality-based training sessions over 5 weeks. The primary outcome is the difference between intervention arms in the incidence of PPD, assessed with an interview 6 months after birth. We will also assess the severity of depressive symptoms, rated weekly online during the first 6 weeks postpartum. Discussion: The results will have implications for future early prophylactic interventions for pregnant women at heightened risk of PPD. If the PACT intervention reduces the incidence of PPD, it can become a feasible, non-invasive prophylactic strategy during pregnancy, with positive mental health implications for these women and their children. Trial registration: ClinicalTrials.gov NCT06046456 registered 21-09-2023, updated 08-07-2024.